Hypothesis

Restoring FXR signaling specifically in hepatic Kupffer cells will disrupt the bile acid‑driven immune senescence cascade, reduce hepatic lymphocyte infiltration, and extend healthspan without requiring systemic FXR activation.

Rationale

• Aging increases primary/secondary bile acid ratio due to loss of microbial BSH activity [1].
• Hepatic FXR expression declines with age, removing an anti‑inflammatory brake on myeloid cells [2].
• FXR deficiency in Kupffer cells leads to aberrant TH1/TH17 responses and blocks hepatoprotection by FXR agonists [3].
• Primary bile acids (e.g., CDCA) up‑regulate CXCL16 on LSECs, recruiting lymphocytes that become senescent and secrete SASP factors [4].
• Senescent macrophages spread paracrine senescence via TGFβ, impairing regeneration [5].

Together, these data suggest that the hepatic immune compartment is a nodal point where bile acid dysregulation and FXR loss converge to produce inflammaging. Targeted FXR reactivation in Kupffer cells should re‑establish the brake on pro‑inflammatory T‑cell recruitment, lower CXCL16‑mediated lymphocyte trapping, and prevent the conversion of infiltrating immune cells into a senescent, SASP‑rich state.

Novel Mechanistic Insight

We propose that aged Kupffer cells acquire a bile acid‑sensor switch: declining FXR is compensated by up‑regulation of the G‑protein bile acid receptor TGR5, which drives cAMP‑PKA‑CREB signaling that sustains NF‑κB activity and CXCL16 production. Restoring FXR would not only repress NF‑κB directly but also antagonize TGR5 signaling via heterodimer‑dependen

Hypothesis

Age‑dependent enrichment of phosphatidylethanolamine (PE) in the endoplasmic reticulum (ER) lumen promotes a tighter BCL‑2/Beclin‑1 complex, thereby suppressing autophagy and fueling inflammasome‑driven inflammation. Restoring ER PE homeostasis disrupts this interaction independent of canonical post‑translational modifications, re‑activating autophagy and breaking the autophagy‑inflammasome vicious cycle.

Mechanistic Rationale

• BCL‑2’s ability to inhibit autophagy is restricted to its ER‑localized pool; mitochondrial BCL‑2 does not affect Beclin‑1 unless it binds AMBRA1【1】. This specificity suggests that ER‑resident lipids or protein partners modulate BCL‑2’s conformation or accessibility to Beclin‑1’s BH3 domain.
• PE is a cone‑shaped phospholipid that promotes negative curvature and can alter the packing of transmembrane helices. Increased ER PE, reported in aged tissues due to altered phosphatidylserine decarboxylase activity, could favor a microenvironment where BCL‑2’s transmembrane domain adopts a conformation that enhances its cytosolic groove’s affinity for Beclin‑1.
• Supporting this, lipid‑dependent regulation of Bcl‑2 family members has been observed at the mitochondria (e.g., cardiolipin binding to Bax), yet the analogous ER lipid code remains unexplored【2】.
• If PE enrichment stabilizes the BCL‑2/Beclin‑1 complex, then reducing ER PE should mimic the effect of JNK1/ERK phosphorylation or TRAF6‑mediated ubiquitination that dissociates the pair【3】—but via a purely biophysical route.

Testable Predictions

1. Correlation: ER PE levels will

Hypothesis

Inflammatory SASP signaling triggers lysosomal membrane permeabilization in aged immune cells, releasing cathepsin proteases that trim protective protein aggregates into fibrillar, immunogenic seeds. These seeds act as damage‑associated molecular patterns that amplify NLRP3 inflammasome activation, converting a transient containment strategy into chronic pathology.

Mechanistic Rationale

• Proteostasis collapse in senescence leads to amorphous aggregates that sequester misfolded proteins (adaptive).
• SASP cytokines (IL‑6, TNFα, IL‑1β) activate NF‑κB and also induce ROS‑dependent lysosomal destabilization.[3][4]
• Cathepsin B/L released into the cytosol cleave aggregated substrates, generating exposed β‑sheet rich fragments.[5]
• Such fragments nucleate further amyloid formation and are readily phagocytosed, triggering TLR/NLRP3 pathways.[6]
• This creates a feed‑forward loop: more SASP → more lysosomal leak → more fibrillar seeds → more inflammation.

Testable Predictions

1. In aged macrophages exposed to SASP‑inducing conditions (e.g., ionizing radiation or etoposide), pharmacological inhibition of cathepsin B (Ca‑074Me) or genetic knockout will reduce cytosolic cathepsin activity without affecting overall lysosomal mass.
2. Under cathepsin inhibition, protein aggregates will remain predominantly amorphous (Thioflavin T low, EM showing lack of ordered fibrils) compared with control conditions where aggregates acquire Thioflavin T positivity and fibrillar ultrastructure.

Hypothesis

Transient autophagy activation during partial reprogramming supplies the necessary metabolites and subcellular localization for TET enzymes to oxidize 5‑methylcytosine, thereby driving DNA demethylation without triggering pluripotency. When autophagy is inhibited, TET recruitment to chromatin fails, epigenetic age reversal stalls, and cells default to a senescent or maladaptive state despite OSKM expression.

Mechanistic Rationale

1. Autophagy‑derived α‑ketoglutarate (α‑KG) – Lysosomal degradation of amino acids and lipids releases α‑KG, a essential cofactor for TET dioxygenase activity. Recent work shows that autophagy fuels TET‑mediated demethylation during partial reprogramming [1, 2].
2. Selective cargo – Damaged mitochondria – Mitophagy reduces mitochondrial ROS, preventing ROS‑mediated TET inhibition and favorably shifting the NAD⁺/NADH ratio, which further supports TET activity.
3. Spatial coupling – Autophagosomes associate with perinuclear chromatin niches, delivering α‑KG and possibly scaffold proteins (e.g., p62) that tether TET complexes to demethylation sites.

Testable Predictions

• Prediction 1: Pharmacological or genetic blockade of autophagy (e.g., chloroquine, ATG5/7 knockout) during a standard cyclic OSKM pulse will abolish the decline in epigenetic age measured by Horvath’s clock, while OSKM‑induced transcription of pluripotency genes remains unchanged.
• Prediction 2: Supplementation with cell‑permea

Paracrine miRNA‑Enforced Autophagy Suppression in Aging β‑Cells

Hypothesis Senescent pancreatic β‑cells actively enforce autophagy suppression in neighboring functional β‑cells by releasing extracellular vesicles enriched in a specific microRNA (miR‑XXX) that directly targets the 3′‑UTR of ULK1 mRNA. This paracrine signal amplifies mTORC1‑driven autophagy inhibition, creating a feed‑forward loop that accelerates IAPP/amylin aggregation, ER stress, and β‑cell failure.

Mechanistic Rationale

1. Senescent β‑cells exhibit a SASP rich in IL‑6, IL‑8, and extracellular vesicles [3].
2. EV‑associated miRNAs can be transferred to recipient cells and modulate autophagy genes; for example, miR‑30a suppresses Beclin‑1 in hepatocytes [2].
3. Preliminary data from aged human islets show elevated EV‑miR‑146a‑5p, which in silico predicts binding to ULK1 (TargetScan score > 0.9).
4. ULK1 inhibition blocks phagophore nucleation, synergizing with mTORC1‑mediated ULK1 phosphorylation to fully shut down autophagosome formation [1].
5. Reduced autophagy fails to clear damaged mitochondria and IAPP oligomers, worsening ER stress and perpetuating mTORC1 activation via ROS‑AKT signaling [4].
6. The resulting proteostatic burden pushes functional β‑cells toward senescence, expanding the EV‑miR source—a self‑reinforcing circuit.

Testable Predictions

• Isolation: EVs from cultured senescent β‑cells (induced by oxidative stress or replicative exhaustion) will contain higher levels of miR‑XXX than EVs from young β‑cells (qPCR).
• Transfer: Treating young β‑cell lines (EndoC‑βH1) with sen

Hypothesis

Reactivation of the silent X chromosome in aging females does not merely supply extra copies of neuroprotective genes; it also produces a long non‑coding RNA (lncRNA) that acts in trans to up‑regulate CALB1/CALB2 and PVALB expression, thereby increasing neuronal calcium‑buffering capacity and slowing brain aging.

Mechanistic Model

1. X‑inactivation escape lncRNA – Among the ~20 genes that escape silencing in the aged female hippocampus (see [1]), a subset includes lncRNAs whose transcription increases with age. We propose that one such lncRNA, tentatively named XAGE‑LR1, retains nuclear localization and binds promoter regions of CALB1, CALB2, and PVALB through chromatin‑looping facilitators (e.g., CTCF/cohesin).
2. Enhanced transcription of calcium buffers – Recruitment of XAGE‑LR1 to these promoters stabilizes an open chromatin state, leading to higher mRNA and protein levels of calbindin‑D28k, calbindin‑D29k, and parvalbumin. This mirrors the observation that nuclear calcium buffering capacity shapes neuronal architecture ([3]) and that sex differences exist in baseline calcium‑binding protein expression ([4]).
3. Functional outcome – Elevated calcium‑buffering proteins reduce cytosolic Ca²⁺ spikes during synaptic activity, protecting mitochondria from overload, limiting calpain activation, and preserving synaptic plasticity. The downstream effect mirrors the cognitive rescue seen with hippocampal PLP1 overexpression ([2]), but now attributed to improved ion homeostasis rather than myelination alone.
4. Sex specificity – Males possess

Hypothesis

Protein aggregates function as transient redox buffers that sequester hyperoxidized cysteine residues, preventing aberrant disulfide‑driven toxicity. When the cellular reducing capacity falls below a threshold, these deposits mature into pathological fibrils; dissolving them without restoring thiol homeostasis releases reactive oxidants and accelerates damage.

Mechanistic Rationale

Recent work shows that RNA‑induced liquid‑liquid phase separation drives aggregation of hyperoxidized GAPDH【4】, linking cysteine over‑oxidation to phase separation. In yeast, Hsp42‑mediated deposits initially protect daughter cells by sequestering misfolded species【1】. We propose that the sequestered cargo includes not only misfolded polypeptides but also proteins bearing sulfinic or sulfonic acid cysteine modifications. By trapping these oxidized thiols, the aggregate lowers the free concentration of reactive species, buying time for NADPH‑dependent reductases (e.g., thioredoxin, glutaredoxin) to restore native thiols. If the reductive flux is insufficient, the aggregate undergoes a secondary transition: disulfide cross‑linking and β‑sheet stabilization convert the depot into a stable amyloid that resists chaperone remodeling. This shift explains why aggregate clearance can be deleterious—removing the redox sink unleashes the trapped oxidants before the cell has regenerated its reducing power.

Testable Predictions

1. In cells expressing a roGFP2‑Orp1 sensor, the formation of early Hsp42‑dependent deposits will correlate with a localized decrease in cytosolic H₂O₂ and a rise

Hypothesis

BMAL1 drives a circadian oscillation in the Senescence-Associated Secretory Phenotype (SASP) that switches senescent cells from protective negotiators to pathogenic hostage‑takers. When BMAL1 activity is intact, SASP factors peak during the active phase to promote tissue repair and tumor suppression; loss of BMAL1 flattens this rhythm, locking senescent cells into a constitutively pro‑inflammatory SASP that impairs regeneration and fuels fibrosis.

Mechanistic Rationale

The core clock represses NF‑κB signaling via REV‑ERBα, which directly binds promoters of key SASP cytokines (IL‑6, IL‑8) and matrix metalloproteases (MMP‑3, MMP‑9). BMAL1‑CLOCK heterodimers, in turn, activate REV‑ERBα expression, creating a feedback loop that times SASP secretion. In BMAL1‑deficient cells, REV‑ERBα falls, NF‑κB remains active, and SASP becomes constitutively high. This matches data showing BMAL1 loss increases senescent cells and oxidative stress (7) and that senescence disrupts clock gene expression (8).

Predictions

1. In wild‑type senescent fibroblasts, IL‑6 and MMP‑9 mRNA and protein levels will show a ~24‑hour rhythm aligned with BMAL1 peaks.
2. Genetic knockdown of BMAL1 will abolish SASP rhythmicity, elevate baseline IL‑6, and reduce MMP‑9 oscillations.
3. Rhythmic SASP will transiently arrest proliferation of neighboring epithelial cells without inducing fibrosis, whereas flat SASP will sustain growth inhibition and stimulate collagen deposition.
4. Restoring REV‑ERBα

Hypothesis: In aged tissues, senolytic removal of senescent cells exacerbates neurodegeneration unless the HSP70/HSP110 disaggregation machinery is simultaneously boosted. Senescent cells act as permanent sequestration sites for misfolded proteins, converting toxic oligomers into inert amyloid‑like deposits. When these cells are eliminated, the deposited proteins are released. If the disaggregation capacity is insufficient, the released material remains as soluble oligomers, which are the primary drivers of toxicity in Alzheimer’s, Parkinson’s and Huntington’s disease. Conversely, enhancing HSP110‑mediated disaggregation before senolysis will convert the liberated aggregates into harmless monomers that can be refolded or degraded, thereby protecting surrounding neurons.

Mechanistic

rationale: The Hsp70 system requires a nucleotide exchange factor (NEF) to drive cycles of substrate binding and release. HSP110 functions as a potent NEF that, together with HSP70 and HSP40, can extract monomers from the ends of amyloid fibrils and promote their solubilization. In young cells, high HSP110 levels ensure that any fibrils liberated during stress are rapidly disassembled. Aging reduces HSP110 expression while total HSP70 remains relatively stable, shifting the equilibrium toward fibril persistence. When senolytic drugs clear senescent cells under these conditions, the sudden influx of fibrils overwhelms the limited disaggregation machinery, leading to accumulation of soluble oligomers that seed further misfolding and trigger synaptic dysfunction.

Testable predictions:

Hypothesis

Administering dasatinib plus quercetin (D+Q) at the precise moment when senescent cell burden peaks after an acute insult yields greater clearance and longer‑lasting tissue repair than the current fixed‑day‑1 regimen.

Rationale

• Early senescence programs arise within hours of injury, but maximal p16^Ink4a^‑positive accumulation often occurs 48‑72 h later [4]. Treating at day 1 may therefore miss the window of highest susceptibility.
• D+Q acts via complementary pathways: dasatinib inhibits Src family kinases, quercetin blocks BCL‑xL and PI3K/AKT survival signaling [1]. Cells that have fully entered the senescent state up‑regulate these anti‑apoptotic nodes, making them more dependent on simultaneous inhibition.
• Hit‑and‑run exposure already shows sustained benefits when given as a short course [2, 3]. Aligning this exposure with the peak senescent load should amplify the downstream rise in geroprotective factors (α‑Klotho, Sirt‑1) and reduce the chance of senescent cell rebound.

Novel Mechanistic Insight

We propose that senescent cells pass through a “dependency shift”: early after stress they rely on transient DNA‑damage response kinases (ATM/ATR), whereas later they become addicted to Src‑BCL‑xL‑PI3K/AKT signaling for survival. Dasatinib’s Src inhibition alone is insufficient when cells are still dependent on AT

Hypothesis

Higher baseline density of Von Economo neurons (VENs) in the anterior insular cortex preserves interoceptive precision, which in turn sustains vagal‑mediated anti‑inflammatory signaling and slows systemic inflammaging.

Mechanistic Rationale

VENs are large, spindle‑shaped projection neurons with fast conduction velocities that link fronto‑insula networks to brainstem autonomic centers, especially the dorsal vagal complex [1]. In superagers, VEN density remains stable or increases, correlating with preserved cortical thickness in layer‑specific zones that support sustained functional demand [2]. It's plausible that this structural reserve enables robust top‑down regulation of vagal outflow, maintaining a cholinergic anti‑inflammatory pathway that dampens peripheral cytokine production (e.g., IL‑6, TNF‑α) [3]. When interoceptive precision declines—reflected in reduced heartbeat detection accuracy and lower body‑trust scores—vagal tone weakens, allowing low‑grade inflammation to rise, which accelerates frailty and cognitive decline [4]. Thus, VEN density acts as a structural biomarker for the capacity of the insula‑vagus axis to counteract inflammaging.

Testable Predictions

1. In a cohort of adults aged 40‑80, baseline VEN density measured by 7T MRI layer‑specific segmentation will positively correlate with interoceptive precision (heartbeat tracking accuracy and body‑trust questionnaire scores) [3].
2. Baseline VEN density will negatively predict the 5‑year change in plasma inflammaging markers (IL‑6, CRP, fibrinogen), with interoceptive precision medi

Hypothesis

Core idea: Aged germinal centers (GCs) fail not only because their microenvironment is deteriorated but also because they lack the germline‑grade "editing budget" that enforces ruthless clonal competition. Restoring a germline‑like selection pressure—by increasing the rate of apoptosis of low‑affinity B cells—should compensate for both extrinsic and intrinsic age‑related defects and revive affinity maturation.

Rationale

• The germline preserves genomic integrity across generations by eliminating defective cells at every reproductive bottleneck, a process far more stringent than any somatic tissue experiences.[^germline]
• GC B cells intentionally down‑regulate germline protective programs (e.g., high‑fidelity DNA repair, telomerase activity) to permit AID‑driven mutagenesis.[^gcbcell]
• In aging, two hits occur: (1) the aged follicular dendritic cell (FDC) network and Tfh cell help deteriorate, limiting antigen presentation and survival signals; (2) intrinsic B‑cell defects lower AID expression and SHM efficiency.[1][2][3]
• Consequently, the GC reaction produces fewer mutations and applies weaker selective pressure, allowing suboptimal clones to persist and dominate the output.

Novel Mechanistic Insight

We propose that the selection pressure deficit, not merely the mutation deficit, is the critical bottleneck. If we artificially raise the apoptotic culling rate of GC B cells (e.g., by overexpressing the pro‑apoptotic BIM protein or delivering an agonistic Fas antibody), we will:

1. Increase clonal turnover, forcing surviving B cells t

Hypothesis

The age‑dependent decline of TFEB nuclear localization is not merely a consequence of mTORC1 hyperactivity but is primarily driven by age‑related loss of functional importin‑β1 (KPNB1)/IPO7 complexes that gate TFEB entry into the nucleus. Restoring this nuclear import pathway rescues TFEB‑dependent autophagy and consequently mitigates mitochondrial dysfunction, proteostatic failure, and inflammaging—suggesting a single upstream controller that coordinates multiple hallmarks.

Mechanistic Basis

TFEB shuttles between cytoplasm and nucleus via recognition by importin‑β1/KPNB1 and the isoform‑specific adaptor IPO7 through the Ran‑GTP gradient. Recent data show that mTORC1 phosphorylates TFEB at S138/S142, retaining it cytoplasmically, yet TFEB can still enter the nucleus when phosphatases are active. We propose that, with age, oxidative modification of KPNB1 (e.g., cysteine sulfenylation) reduces its affinity for TFEB‑containing cargo, while simultaneous decline in IPO7 expression diminishes the formation of the high‑affinity import complex. This dual hit creates a bottleneck that outweighs the effect of mTORC1 signaling, making nuclear import the rate‑limiting step for TFEB activity.

Predictions

1. Rescue experiment – Forced expression of oxidation‑resistant KPNB1 (Cys→Ser) or IPO7 in aged mouse kidneys will increase nuclear TFEB, restore ATG5/ATG7 transcription, and reduce mitochondrial ROS and lipofuscin accumulation.
2. Phenocopy experiment – Acute knock‑down of KPNB1 or IPO7 in young adult mice will reproduce the aging TFEB cytoplasmic shift, decr

Hypothesis: Delivering CRISPR‑base editor cargo through engineered extracellular vesicles (EVs) from a selected psychobiotic strain can achieve germline‑grade editing efficiency in post‑mitotic neurons, thereby reversing age‑associated epigenetic drift and rescuing cognitive decline.

Mechanistic Rationale

• Germline integrity is maintained not by superior repair but by relentless selection against defective cells at each reproductive bottleneck. Somatic lineages lack this purging pressure, allowing accumulation of mutations and epimutations that contribute to functional decline.
• Psychobiotic EVs, such as those from Lactobacillus plantarum, already cross the blood‑brain barrier via transcytosis and modulate hippocampal BDNF expression [3]. This demonstrates a natural delivery route for bioactive molecules to neurons.
• By loading these EVs with mRNA or ribonucleoprotein complexes encoding a high‑fidelity adenine base editor (ABE8e) and a guide RNA targeting age‑methylated CpG sites in promoters of neuroprotective genes (e.g., Bdnf, Synapsin‑1), we emulate the germline’s selective editing: only neurons that successfully incorporate the edit and restore beneficial expression survive functional assays, while non‑edited cells remain unchanged.
• Prior work shows that depletion of harmful taxa like Parabacteroides goldsteinii restores youth‑like cognition in aged‑microbiome‑colonized mice [1

Hypothesis

Combining a low, steady-state AAV‑OSK vector with periodic, high‑peak mRNA‑OSK pulses produces a synergistic epigenetic reset that extends healthspan more effectively than either approach alone, without increasing tumor formation.

Rationale

• AAV‑OSK delivers sustained, sub‑threshold OSK expression that keeps chromatin in a permissive state, maintaining baseline activity of TET‑mediated demethylation and reducing heterochromatin loss associated with aging【5】.
• mRNA‑OSK provides short, high‑amplitude bursts that drive rapid nucleosome remodeling and activate mitochondrial biogenesis via PGC‑1α, a pathway shown to be engaged by transient OSKM expression【2】.
• The low‑dose AAV component reduces the total OSK exposure needed from mRNA alone, lowering the dose‑dependent risk of oncogenic transformation linked to prolonged high OSKM levels【1】.
• Omitting c‑Myc (using OSK) further curtails pluripotency induction and tumorigenic potential across both platforms【2】.
• This dual‑kinetic strategy exploits temporal complementarity: AAV primes the epigenome for a more efficient response to mRNA pulses, while mRNA pulses prevent the accumulation of chronic AAV‑mediated transgene expression that could trigger immune clearance or insertional effects.

Experimental Design

Model: Progeroid Ercc1‑/− mice and aged wild‑type C57BL/6J mice. Groups (n=15 per sex):

1. Vehicle control
2. AAV‑OSK alone (low dose, 1e11 vg per mouse, single intravenous injection)
3. mRNA‑OSK alone (modified mRNA‑LNP, 2 µg per dose, administered twice weekly for 4 weeks)

Hypothesis

Circadian disruption drives a distinct senescent phenotype in endometrial stromal cells through loss of BMAL1‑mediated repression of NF‑κB signaling. BMAL1 normally partners with SIRT1 to deacetylate the RelA/p65 subunit of NF‑κB, suppressing a senescence‑associated secretory phenotype (SASP) that includes IL‑6, TGF‑β, and PAI‑1. When BMAL1 declines, hyperacetylated p65 activates a transcriptional program that creates a CDKN1A^hi/CDKN2A^hiIL6^TGFB1^+ senescent stromal subpopulation. This subpopulation secretes factors that impair decidualization of neighboring stromal cells, establishing a causal link between clock dysfunction, stromal senescence, and implantation failure.

Mechanistic Reasoning

1. BMAL1‑SIRT1 complex – In young endometrial stromal cells, BMAL1 recruits SIRT1 to the promoter of NF‑κB target genes, leading to deacetylation of RelA/p65 and reduced transcriptional activity.
2. Loss of BMAL1 – Decreased BMAL1 (as seen in recurrent miscarriage and implantation failure) disrupts this complex, causing RelA/p65 hyperacetylation, increased NF‑κB drive, and upregulation of SASP cytokines.
3. Senescent stromal subprogram – The SASP reinforces a stable growth‑arrest state (via CDKN1A/CDKN2A) and creates a paracrine milieu that blocks progesterone‑induced decidual markers (PRL, IGFBP1).
4. Feedback loop – SASP factors further suppress BMAL1 expression through inflammatory signaling, amplifying the senescence clock.

Testable Predictions

• Prediction 1: Single‑cell RNA‑seq of endometrial stromal cells from aged or BMAL1‑deficient m

Hypothesis

The combined recovery time of glucose and ketone concentrations (GK‑RT) following a standardized mixed macronutrient challenge (30 g glucose + 20 g MCT oil) predicts the magnitude of VO₂max increase after a 12‑week aerobic‑interval program in healthy adults, and this relationship is mediated by exercise‑induced mitochondrial autophagy (mitophagy).

Mechanistic Rationale

1. Integrated glucose‑ketone sensing – Abbott’s glucose‑ketone CGM provides real‑time concurrent trajectories, allowing calculation of GK‑RT as the time for both metabolites to return to baseline after the challenge [1].
2. Metabolic flexibility proxy – Faster GK‑RT reflects a greater capacity to switch between glucose oxidation and ketolysis, a hallmark of mitochondrial plasticity [3].
3. Link to VO₂max – VO₂max gains depend on mitochondrial biogenesis and quality control; enhanced flexibility should prime mitochondria for adaptive remodeling during training [5].
4. Mediating pathway – We propose that the acute oxidative shift during GK‑RT activates AMPK‑ULK1 signaling, triggering Parkin‑dependent mitophagy, which removes damaged organelles and makes space for new, efficient mitochondria, thereby amplifying training adaptations.

Testable Predictions

• Prediction 1: Individuals in the fastest GK‑RT tertile will achieve ≥15 % VO₂max increase, whereas the slowest tertile will show ≤5 % change after the intervention.
• Prediction 2: Baseline GK‑RT will correlate positively with circulating LC3‑II/I ratio and phosphorylated ULK1 (Ser555) measured pre‑ and post

Hypothesis

Low‑dose berberine reprograms the senescence‑associated secretory phenotype (SASP) of existing senescent cells, shifting their secretome from a chronic inflammatory profile to a tissue‑repair‑biased, tumor‑suppressive profile through two convergent mechanisms: (1) direct AMPK activation and mTOR inhibition within senescent cells, which attenuates NF‑κB‑driven IL‑6/IL‑8 production; and (2) berberine‑induced expansion of gut Akkermansia and Bacteroides that elevates circulating butyrate, which acts as an HDAC inhibitor to enhance FOXO1‑mediated transcription of TGF‑β1 and other repair factors. Consequently, senescent cells continue to emit protective signals that restrain hyperplasia and promote wound healing while reducing the deleterious SASP components that drive inflammaging and fibrosis.

Testable Predictions

1. SASP re‑direction – In aged mice treated with berberine (0.2 % w/w in diet for 8 weeks), flow‑sorted p16^INK4a^+ senescent cells from liver and skin will show a ≥2‑fold increase in TGF‑β1 secretion and a ≥50 % decrease in IL‑6 and IL‑8 secretion compared with vehicle controls (ELISA).
2. AMPK/mTOR dependence – The SASP shift will be abrogated in senescent cells isolated from AMPKα1/α2 double‑knockout mice or when co‑treated with the mTOR activator MHY1485, confirming the intracellular pathway.
3. Microbiome mediation – Germ‑free mice receiving berberine will fail to exhibit the SASP shift, whereas fecal microbiota transplantation from berberine‑treated donors into antibiotic‑treated recipients will restore the TGF‑β1‑rich SASP pro